MBX Biosciences strengthens its Board along with raising $34.6M Series A financing led by Frazier Healthcare Partners
– USA, IN – MBX Biosciences, a drug discovery company focused on rare endocrine diseases, today announced the closing of a $34.6 million Series A financing led by Frazier Healthcare Partners, with participation from OrbiMed, New Enterprise Associates, Indiana Philanthropic Venture Fund, Indiana Seed Fund III and Twilight Venture Partners II.…